C. V. van Els

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Cécile A.c.m. Van Els, Cécile Acm Van Els, Cécile Van Els, Cécile A C M Van Els, C.a.c.m. Van Els, Cécile A. Van Els, Cecile A. C. M. Van Els, C A Van Els, C Van Els, C.a. Van Els, Cécile A Van Els, Cécile A. C. M. Van Els, Cécile A. C. M. Van Els, C A C M Van Els, Cecile A C M Van Els, Cecile Van Els, Cecile A.c.m. Van Els
Publication record
113 papers · 3,177 citations · H-index 31

PAPERS

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment
20232 citationsauthor #19
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
20233 citationsauthor #28
A semi high-throughput whole blood-based flow cytometry assay to detect and monitor Bordetella pertussis-specific Th1, Th2 and Th17 responses
20235 citationsauthor #10
CD4+ T cell-mediated recognition of a conserved cholesterol-dependent cytolysin epitope generates broad antibacterial immunity.
20236 citationsauthor #12
Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adults
20239 citationsauthor #8
Remembering Ad de Jong
20230 citationsauthor #1
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases.
202336 citationsauthor #32
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
2022110 citationsauthor #28
SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
202217 citationsauthor #5
Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months
202229 citationsauthor #11
Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals
202223 citationsauthor #6
A synthetic human 3D in vitro lymphoid model enhancing B-cell survival and functional differentiation
202220 citationsauthor #6
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
202217 citationsauthor #27
Non-linear in cis-spliced bacterial MHC class II epitopes are formed in human monocyte-derived dendritic cells and are recognized by human CD4+ T cells
20221 citationsauthor #7
SARS-CoV-2 Delta Breakthrough Infections in Vaccinated Patients with Immune-Mediated Inflammatory Diseases Using Immunosuppressants – Data from Two Controlled Prospective Cohort Studies
20220 citationsauthor #29
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
202241 citationsauthor #29
Corrigendum: Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response Up to 10 Months
20227 citationsauthor #11
Long Lasting Antibodies From Convalescent Pertussis Patients Induce ROS Production and Bacterial Killing by Human Neutrophils
20224 citationsauthor #7
Reduced Bordetella pertussis-specific CD4+ T-Cell Responses at Older Age
20227 citationsauthor #7
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
202224 citationsauthor #18
LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
202113 citationsauthor #16
Longitudinal Characterization of the Mumps-Specific HLA-A2 Restricted T-Cell Response after Mumps Virus Infection
20212 citationsauthor #5
COVID-19 vaccination: the VOICE for patients with cancer
202155 citationsauthor #16
CD4+ T cell recognition of pneumolysin, a pore-forming cytolysin derived from Streptococcus pneumoniae presented by a common HLA allotype
20210 citationsauthor #9
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
2021134 citationsauthor #19
Genetic Analysis Reveals Differences in CD8+ T Cell Epitope Regions That May Impact Cross-Reactivity of Vaccine-Induced T Cells against Wild-Type Mumps Viruses
20217 citationsauthor #4
Novel mumps virus epitopes reveal robust cytotoxic T cell responses after natural infection but not after vaccination
20215 citationsauthor #4
Diminished Pneumococcal-Specific CD4+ T-Cell Response is Associated With Increased Regulatory T Cells at Older Age
20217 citationsauthor #8
Children and adults with mild COVID-19 symptoms develop memory T cell immunity to SARS-CoV-2
20212 citationsauthor #11
Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube
202045 citationsauthor #17
Vaccines to Protect Older Adults against Pneumococcal Disease.
20209 citationsauthor #5
Uncovering Distinct Primary Vaccination-Dependent Profiles in Human Bordetella pertussis Specific CD4+ T-Cell Responses Using a Novel Whole Blood Assay
202016 citationsauthor #12
Acellular Pertussis Vaccines Induce Anti-pertactin Bactericidal Antibodies Which Drives the Emergence of Pertactin-Negative Strains
202049 citationsauthor #8
Superior B. pertussis Specific CD4+ T-Cell Immunity Imprinted by Natural Infection.
20198 citationsauthor #3
Discovery of Salmonella trehalose phospholipids reveals functional convergence with mycobacteria
201925 citationsauthor #12
Prediction and Validation of Immunogenic Domains of Pneumococcal Proteins Recognized by Human CD4+ T Cells
201914 citationsauthor #5
The Human CD4+ T Cell Response against Mumps Virus Targets a Broadly Recognized Nucleoprotein Epitope
201912 citationsauthor #6
Identification of naturally processed mumps virus epitopes by mass spectrometry: Confirmation of multiple CD8+ T cell responses in mumps patients.
201912 citationsauthor #5
Diversity of aging of the immune system classified in the cotton rat (Sigmodon hispidus) model of human infectious diseases
20189 citationsauthor #5
Mumps infection but not childhood vaccination induces persistent polyfunctional CD8+ T-cell memory.
201818 citationsauthor #8
Erratum: Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination
201813 citationsauthor #13
Vaccine antigens modulate the innate response of monocytes to Al(OH)3
201816 citationsauthor #3
Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine
201814 citationsauthor #7
Novel identified aluminum hydroxide-induced pathways prove monocyte activation and pro-inflammatory preparedness.
201827 citationsauthor #3
Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients
201816 citationsauthor #9
Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1
20185 citationsauthor #7
Arginine (Di)methylated Human Leukocyte Antigen Class I Peptides Are Favorably Presented by HLA-B*07.
201736 citationsauthor #7
Erratum for Carbonetti et al., “Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development”
20171 citationsauthor #8
Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis
201723 citationsauthor #6
Transcriptome signature for dampened Th2 dominance in acellular pertussis vaccine-induced CD4+ T cell responses through TLR4 ligation
201618 citationsauthor #7
Association of Vitamin D Receptor Polymorphism with Susceptibility to Symptomatic Pertussis
201614 citationsauthor #7
The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections
20163 citationsauthor #10
Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine
201648 citationsauthor #9
Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity*
201659 citationsauthor #8
Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells
201622 citationsauthor #7
Development of an IFNγ ELISPOT for the analysis of the human T cell response against mumps virus.
201610 citationsauthor #5
Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development
201616 citationsauthor #8
Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
201643 citationsauthor #7
Modulation of the CD4(+) T cell response after acellular pertussis vaccination in the presence of TLR4 ligation.
201538 citationsauthor #7
Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation
201529 citationsauthor #11
Ex vivo peptide-MHC II tetramer analysis reveals distinct end-differentiation patterns of human pertussis-specific CD4(+) T cells following clinical infection.
20158 citationsauthor #5
Waning and aging of cellular immunity to Bordetella pertussis.
201530 citationsauthor #3
Identification of Pertussis-Specific Effector Memory T Cells in Preschool Children
201521 citationsauthor #10
Differential B-Cell Memory Around the 11-Month Booster in Children Vaccinated With a 10- or 13-Valent Pneumococcal Conjugate Vaccine
201515 citationsauthor #10
Roads to the development of improved pertussis vaccines paved by immunology
201565 citationsauthor #4
Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic
201517 citationsauthor #7
Extended O-GlcNAc on HLA Class-I-Bound Peptides.
201575 citationsauthor #8
Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome
201553 citationsauthor #9
Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD)
2014179 citationsauthor #6
Bordetella pertussis Naturally Occurring Isolates with Altered Lipooligosaccharide Structure Fail To Fully Mature Human Dendritic Cells
201417 citationsauthor #8
Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter
201419 citationsauthor #1
Molecular Signatures of the Evolving Immune Response in Mice following a Bordetella pertussis Infection
201438 citationsauthor #10
Age Related Differences in Dynamics of Specific Memory B Cell Populations after Clinical Pertussis Infection
201428 citationsauthor #10
Bordetella pertussis Proteins Dominating the Major Histocompatibility Complex Class II-Presented Epitope Repertoire in Human Monocyte-Derived Dendritic Cells
201413 citationsauthor #8
Impaired Immune Response to Vaccination against Infection with Human Respiratory Syncytial Virus at Advanced Age
201416 citationsauthor #5
Mumps Serum Antibody Levels Before and After an Outbreak to Assess Infection and Immunity in Vaccinated Students
201423 citationsauthor #7
Toward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis Immunoproteome
201438 citationsauthor #1
Loss of Multi-Epitope Specificity in Memory CD4+ T Cell Responses to B. Pertussis with Age
201314 citationsauthor #9
Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis
2012124 citationsauthor #11
Resurgence of pertussis calls for re-evaluation of pertussis animal models
201233 citationsauthor #6
Fast, Antigen-Saving Multiplex Immunoassay To Determine Levels and Avidity of Mouse Serum Antibodies to Pertussis, Diphtheria, and Tetanus Antigens
201128 citationsauthor #6
Differential Effect of TLR2 and TLR4 on the Immune Response after Immunization with a Vaccine against Neisseria meningitidis or Bordetella pertussis
201054 citationsauthor #8
Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.
201021 citationsauthor #7
Quality-control issues and approaches in vaccine development
200945 citationsauthor #3
Hyperproliferation of B Cells Specific for a Weakly Immunogenic PorA in a Meningococcal Vaccine Model
20089 citationsauthor #5
Immunodominance in Mouse and Human CD4+ T-Cell Responses Specific for the Bordetella pertussis Virulence Factor P.69 Pertactin
200817 citationsauthor #11
Identifying the epitope-specific T cell response to virus infections.
200710 citationsauthor #4
Stable Isotope Tagging of Epitopes
200627 citationsauthor #10
Heterologous prime-boost strategy to overcome weak immunogenicity of two serosubtypes in hexavalent Neisseria meningitidis outer membrane vesicle vaccine.
200620 citationsauthor #3
Mass Tag-Assisted Identification of Naturally Processed HLA Class II-Presented Meningococcal Peptides Recognized by CD4+ T Lymphocytes
200529 citationsauthor #11
HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells.
200426 citationsauthor #11
Major Histocompatibility Complex Class I Peptide Presentation after Salmonella enterica Serovar Typhimurium Infection Assessed via Stable Isotope Tagging of the B27-Presented Peptide Repertoire
200410 citationsauthor #5
Identification of Immunodominant Epitopes Derived from the Respiratory Syncytial Virus Fusion Protein That Are Recognized by Human CD4 T Cells
200339 citationsauthor #9
Vigorous but Short-Term Gamma Interferon T-Cell Responses against a Dominant HLA-A*02-Restricted Measles Virus Epitope in Patients with Measles
200332 citationsauthor #8
Dynamics of measles virus protein expression are reflected in the MHC class I epitope display.
200318 citationsauthor #8
Autoreactivity against induced or upregulated abundant self-peptides in HLA-A*0201 following measles virus infection.
200340 citationsauthor #12
T Cell Responses in Acute Measles
200230 citationsauthor #1
In vitro processing and presentation of a lipidated cytotoxic T-cell epitope derived from measles virus fusion protein.
200113 citationsauthor #7
A single naturally processed measles virus peptide fully dominates the HLA‐A*0201‐associated peptide display and is mutated at its anchor position in persistent viral strains
200080 citationsauthor #1
Anergic T cells actively suppress T cell responses via the antigen‐presenting cell
1998174 citationsauthor #4

TIMELINE

1985 18 citations

1987 27 citations

1989 2 citations

1990 137 citations

1991 21 citations

1993 67 citations

1994 75 citations

1996 29 citations

1998 174 citations

2000 80 citations

2001 13 citations

2002 30 citations

2003 129 citations

2004 36 citations

2005 29 citations

2006 47 citations

2007 10 citations

2008 26 citations

2009 45 citations

2010 75 citations

2011 28 citations

2012 157 citations

2013 14 citations

2014 371 citations

2015 351 citations

2016 233 citations

2017 60 citations

2018 118 citations

2019 71 citations

2020 119 citations

2021 225 citations

2022 300 citations

2023 61 citations

C. V. van Els

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT